Kate Moss’ sister Lottie shares story of ‘scary’ Ozempic overdose

Lottie Moss has a warning for anyone considering taking Ozempic.

The younger sister of Kate Moss got candid about her struggles with the type 2 diabetes drug many have used for weight loss calling it “the worst decision I ever made”, in an episode of her Dream On podcast.

“I felt so sick one day, I said to my friend, ‘I can’t keep any water down. I can’t keep any food down, no liquids, nothing. I need to go to the hospital. I feel really sick,’” Moss said in an episode titled, My Ozempic Hell: I Had Seizures, A&E, Weight Loss.

Know the news with the 7NEWS app: Download today

She shared that she was sent to the emergency room where a nurse found out the dosage Moss had been taking and told her, “’Oh my god, that’s so not what you’re meant to be taking.’”

The 26-year-old admitted that while she received the medication through a doctor, it wasn’t exactly her doctor.

“The amount that I was taking was for people who were 100kg and over and I’m in the 50s range,” she said.

“It’s these small things I wish I’d known before taking it.”

While in the hospital, Moss had some intense experiences as a result of the overdose.

“I literally had a seizure from how dehydrated I was, which honestly was the scariest thing that’s ever happened to me in my life.

“My friend had to hold my feet down. It was so scary, the whole situation. My face was clenching up, my whole body was tense.”

Moss then slammed the Ozempic trend, saying it’s harmful to body positive images — referring back to the trends that were all the rage when her sister Kate was rising to fame.

“This heroin-chic trend right now coming back, which was something that happened in the ‘90s, we should not be going back there,” Moss said.

“Where did body positivity go?”

But while stars like Moss, Macy Gray, Sharon Osbourne, Rebel Wilson and more have admitted to using Ozempic and similar type 2 diabetes drugs to shed some weight, a rep for Novo Nordisk, the pharmaceutical company that makes Ozempic, previously said the drug is “not approved for chronic weight management.”

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! Todays Chronic is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – todayschronic.com. The content will be deleted within 24 hours.

Leave a Comment